V
Veru D
D
VERU
3.80000
USD
0.10
(2.65%)
مغلق
حجم التداول
1,197
الربح لكل سهم
-2
العائد الربحي
-
P/E
1
حجم السوق
55,671,490
الأخبار المقالات
العنوان: Veru Inc
القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.